Top Stories

(2019 – 2025) Amifostine Market Size, CAGR Status, Market trends, Analysis and Forecast | 360 Market Updates| North America, Europe, Asia & Pacific


Report Title:- “Global Amifostine Market Insights, Forecast to 2025”

Amifostine Market Report 2019 provides the newest industry data and industry future trends, allowing you to identify the products and end users driving Revenue growth and profitability. The industry report lists the leading competitors and provides the insights strategic industry Analysis of the key factors influencing the market.

This report studies the global Amifostine Market analyses and researches the Amifostine development status and forecast in the United States, EU, Japan, China, India, and Southeast Asia. This report focuses on the top players in the global market.

Get a Sample PDF of Report @

Amifostine (Ethiofos) is a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents. It is marketed by Clinigen Group under the trade name Ethyol.

Amifostine is a pro-drug which is activated to the free thiol metabolite at the tissue site. The thiol metabolite is responsible for most of the cytoprotective and radioprotective properties of amifostine. It is readily taken up by cells where it binds to and detoxifies reactive metabolites of platinum and alkylating agents as well as scavenges free radicals. Other possible effects include inhibition of apoptosis, alteration of gene expression and modification of enzyme activity. Healthy cells are preferentially protected because amifostine and metabolites are present in healthy cells at 100-fold greater concentrations than in tumour cells.

, Consumption of amifostine mainly concentrates in North America. In 2016, the region consumed 780 K Unit, holding about 52% market share globally. The follower is Asia-Pacific, with about 41% consumption share.

, The market is relatively concentrated and there are just a few suppliers in the market, such as Clinigen Group, Sun Pharmaceutical, Merro Pharmaceutical and so on. Clinigen Group acquired the business from AstraZeneca in the year of 2014 and signed an agreement with Cumberland in the year of 2016. Under the agreement, Cumberland acquired the exclusive rights to commercialize Ethyol in the United States. Merro Pharmaceutical own the largest sales share in China.

, Amifostine shows good effect in reducing harmful effects of cisplatin chemotherapy on kidneys in women treated for advanced ovarian cancer as well as relieving dry mouth problems (xerostomia) with head and neck cancer patients undergoing radiation treatment. It is estimated that the amifostine market will keep upward tendency and to be worthy of 49.99 million USD in 2023 globally.

, The Global Amifostine market is valued at 48 million US$ in 2018 and will reach 57 million US$ by the end of 2025, growing at a CAGR of 2.2% during 2019-2025. The objectives of this study are to define, segment, and project the size of The Amifostine market based on company, product type, end user and key regions.

With tables and figures helping analyze worldwide Global Amifostine market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Share your query before purchasing this report @

List of Major Amifostine market competition by top manufacturers, with production, price, and revenue (value) and market share for each manufactures: –

  • Clinigen Group
  • Sun Pharmaceutical
  • Taj Pharmaceuticals
  • Merro Pharmaceutical
  • Luye Pharma
  • Mingren Pharma

    The report also focuses on global major leading industry players of Global Amifostine market providing information such as company profiles, product picture, and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis are also carried out. The Global Amifostine market development trends and marketing channels are analyzed. Finally, the feasibility of new investment projects is assessed and overall research conclusions offered.

    By the product type, the market is primarily split into:

  • 400mg/Dose
  • 500mg/Dose

    Look into Table of Content of Amifostine Market Report at @

    By the end users/application, this report covers the following segments:

  • Head and Neck Cancer Adjuvant Therapy
  • Others

    The study objectives of this report are:

    • To study and analyze the global Amifostine market size (value and volume) by company, key regions/countries, products and application, history data from 2014 to 2018, and forecast to 2025.
    • To understand the structure of the Amifostine market by identifying its various sub-segments.
    • To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    • Focuses on the key global Amifostine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in the next few years.
    • To analyze the Amifostine with respect to individual growth trends, future prospects, and their contribution to the total market.
    • To protect the value and volume of Amifostine submarkets, with respect to key regions (along with their respective key countries).
    • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
    • To strategically profile the key players and comprehensively analyze their growth strategies.

    Purchase this report (Price 3900 USD for a single-user license) @


    About 360 Market Updates:

    360 Market Updates is the credible source for gaining the market reports that will provide you with the lead your business needs. At 360 Market Updates, our objective is providing a platform for many top-notch market research firms worldwide to publish their research reports, as well as helping the decision makers in finding most suitable market research solutions under one roof. Our aim is to provide the best solution that matches the exact customer requirements. This drives us to provide you with custom or syndicated research reports.

    Contact Us:

    Name: Mr. Ajay More

    Email: [email protected]

    Organization: 360 Market Updates

    Phone: +14242530807/+44 203 239 8187